These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 12107848)

  • 1. Cyclo-oxygenase inhibition reduces tumour growth and metastasis in an orthotopic model of breast cancer.
    Connolly EM; Harmey JH; O'Grady T; Foley D; Roche-Nagle G; Kay E; Bouchier-Hayes DJ
    Br J Cancer; 2002 Jul; 87(2):231-7. PubMed ID: 12107848
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antimetastatic activity of a cyclooxygenase-2 inhibitor.
    Roche-Nagle G; Connolly EM; Eng M; Bouchier-Hayes DJ; Harmey JH
    Br J Cancer; 2004 Jul; 91(2):359-65. PubMed ID: 15213717
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cyclooxygenase inhibitors retard murine mammary tumor progression by reducing tumor cell migration, invasiveness and angiogenesis.
    Rozic JG; Chakraborty C; Lala PK
    Int J Cancer; 2001 Aug; 93(4):497-506. PubMed ID: 11477553
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cyclooxygenase inhibitors suppress angiogenesis and reduce tumor growth in vivo.
    Sawaoka H; Tsuji S; Tsujii M; Gunawan ES; Sasaki Y; Kawano S; Hori M
    Lab Invest; 1999 Dec; 79(12):1469-77. PubMed ID: 10616198
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prostaglandin E2 receptor EP4 as the common target on cancer cells and macrophages to abolish angiogenesis, lymphangiogenesis, metastasis, and stem-like cell functions.
    Majumder M; Xin X; Liu L; Girish GV; Lala PK
    Cancer Sci; 2014 Sep; 105(9):1142-51. PubMed ID: 24981602
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Celecoxib inhibits angiogenesis by inducing endothelial cell apoptosis in human pancreatic tumor xenografts.
    Raut CP; Nawrocki S; Lashinger LM; Davis DW; Khanbolooki S; Xiong H; Ellis LM; McConkey DJ
    Cancer Biol Ther; 2004 Dec; 3(12):1217-24. PubMed ID: 15477758
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of cyclooxygenase-2 suppresses angiogenesis and the growth of prostate cancer in vivo.
    Liu XH; Kirschenbaum A; Yao S; Lee R; Holland JF; Levine AC
    J Urol; 2000 Sep; 164(3 Pt 1):820-5. PubMed ID: 10953162
    [TBL] [Abstract][Full Text] [Related]  

  • 8. COX-2 selective inhibition reverses the trophic properties of gastrin in colorectal cancer.
    Yao M; Song DH; Rana B; Wolfe MM
    Br J Cancer; 2002 Aug; 87(5):574-9. PubMed ID: 12189559
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selective cyclooxygenase (COX)-1 or COX-2 inhibitors control metastatic disease in a murine model of breast cancer.
    Kundu N; Fulton AM
    Cancer Res; 2002 Apr; 62(8):2343-6. PubMed ID: 11956094
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of cyclooxygenase-2 by rofecoxib attenuates the growth and metastatic potential of colorectal carcinoma in mice.
    Yao M; Kargman S; Lam EC; Kelly CR; Zheng Y; Luk P; Kwong E; Evans JF; Wolfe MM
    Cancer Res; 2003 Feb; 63(3):586-92. PubMed ID: 12566300
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Orthotopic implantation of a colon cancer xenograft induces high expression of cyclooxygenase-2.
    Shoji T; Konno H; Tanaka T; Sakaguchi T; Sunayama K; Baba M; Kamiya K; Ohta M; Kaneko T; Igarashi A; Nakamura S
    Cancer Lett; 2003 Jun; 195(2):235-41. PubMed ID: 12767532
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting COX-2 and EP4 to control tumor growth, angiogenesis, lymphangiogenesis and metastasis to the lungs and lymph nodes in a breast cancer model.
    Xin X; Majumder M; Girish GV; Mohindra V; Maruyama T; Lala PK
    Lab Invest; 2012 Aug; 92(8):1115-28. PubMed ID: 22641101
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunotherapy of mammary adenocarcinoma metastases in C3H/HeN mice with chronic administration of cyclo-oxygenase inhibitors alone or in combination with IL-2.
    Khoo NK; Chan FP; Saarloos MN; Lala PK
    Clin Exp Metastasis; 1992 Jul; 10(4):239-52. PubMed ID: 1617832
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combination of a selective cyclooxygenase-2 inhibitor with epidermal growth factor receptor tyrosine kinase inhibitor ZD1839 and protein kinase A antisense causes cooperative antitumor and antiangiogenic effect.
    Tortora G; Caputo R; Damiano V; Melisi D; Bianco R; Fontanini G; Veneziani BM; De Placido S; Bianco AR; Ciardiello F
    Clin Cancer Res; 2003 Apr; 9(4):1566-72. PubMed ID: 12684433
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cyclo-oxygenase-2 enhances basic fibroblast growth factor-induced angiogenesis through induction of vascular endothelial growth factor in rat sponge implants.
    Majima M; Hayashi I; Muramatsu M; Katada J; Yamashina S; Katori M
    Br J Pharmacol; 2000 Jun; 130(3):641-9. PubMed ID: 10821793
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapeutic potential of selective cyclooxygenase-2 inhibitors in the management of tumor angiogenesis.
    Gately S; Kerbel R
    Prog Exp Tumor Res; 2003; 37():179-92. PubMed ID: 12795055
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Limited anti-inflammatory efficacy of cyclo-oxygenase-2 inhibition in carrageenan-airpouch inflammation.
    Wallace JL; Chapman K; McKnight W
    Br J Pharmacol; 1999 Mar; 126(5):1200-4. PubMed ID: 10205009
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Celecoxib inhibits vascular endothelial growth factor expression in and reduces angiogenesis and metastasis of human pancreatic cancer via suppression of Sp1 transcription factor activity.
    Wei D; Wang L; He Y; Xiong HQ; Abbruzzese JL; Xie K
    Cancer Res; 2004 Mar; 64(6):2030-8. PubMed ID: 15026340
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection of differentially expressed genes in human colon carcinoma cells treated with a selective COX-2 inhibitor.
    Zhang Z; DuBois RN
    Oncogene; 2001 Jul; 20(33):4450-6. PubMed ID: 11494140
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cyclooxygenase-2 inhibition decreases primary and metastatic tumor burden in a murine model of orthotopic lung adenocarcinoma.
    Diperna CA; Bart RD; Sievers EM; Ma Y; Starnes VA; Bremner RM
    J Thorac Cardiovasc Surg; 2003 Oct; 126(4):1129-33. PubMed ID: 14566258
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.